Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01601535
Title Study of MLN8237 in Combination With Irinotecan and Temozolomide
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors New Approaches to Neuroblastoma Therapy Consortium
Indications

neuroblastoma

Therapies

Alisertib + Irinotecan + Temozolomide

Age Groups: adult | child
Covered Countries USA | CAN


No variant requirements are available.